11:09 AM EST, 11/15/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving lower late Friday morning, declining 0.85% to 1,302.64 on the S&P Europe Select ADR Index, which is down about 2.8% for the week.

From continental Europe, the gainers were led by financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) and pharmaceutical company Ascendis Pharma ( ASND ) , which rose 3.2% and 2.7%, respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and financial services company Banco Santander (SAN), which increased 2.3% and 2.2%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company Cellectis ( CLLS ) , which fell 9.3% and 6.8%, respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company argenx (ARGX), which lost 6.2% and 4.5%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm ( TCBP ) and financial services company Lloyds Banking Group ( LYG ) , which advanced 16% and 2%, respectively. They were followed by tobacco company British American Tobacco ( BTI ) and insurance company Prudential (PUK), which were up 1.9% and 1.5%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Biodexa Pharmaceuticals ( BDRX ) , which tumbled 20% and 12%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and Bicycle Therapeutics ( BCYC ) , which dropped 5.7% and 5.5%, respectively.